Tumor tissues underwent immuno-histochemical analysis, showing decreased levels of Ki67 and N-Myc (Figure 5D, 5E) and increased phosphorylation of N-Myc at threonine 58 in the N78 treatment groups (Figure 5F). The gene discussed is MYCN; the disease is neoplasm.